BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohamed MF, Minocha M, Trueman S, Feng T, Enejosa J, Fisniku O, Othman AA. Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate. Clin Pharmacol Drug Dev 2021;10:299-306. [PMID: 32648334 DOI: 10.1002/cpdd.844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohamed MF, Coppola S, Feng T, Camp HS, Kim E, Othman AA. Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects. Clin Pharmacol Drug Dev 2021. [PMID: 34109764 DOI: 10.1002/cpdd.957] [Reference Citation Analysis]
2 Muensterman E, Engelhardt B, Gopalakrishnan S, Anderson JK, Mohamed MF. Upadacitinib pharmacokinetics and exposure-response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trials. Clin Transl Sci 2021. [PMID: 34464029 DOI: 10.1111/cts.13146] [Reference Citation Analysis]
3 Mohamed MF, Gopalakrishnan S, Teixeira HD, Othman AA. Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 Doses. J Clin Pharmacol 2021;61:628-35. [PMID: 33156550 DOI: 10.1002/jcph.1782] [Cited by in F6Publishing: 1] [Reference Citation Analysis]